Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Peter Abramowitz
Period: Reporting periods mapped to calendar 2025 Q1 – 2026 Q3 (7 quarters; questions recorded in 4).
- Questions
- 17on tracked calls
- Challenge rate
- 6%1 of 17 questions
- Companies
- 8questioned at least once
- Reporting periods
- 4with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right. See how we grade analysts on earnings-call questions.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 17 of 17 questions from 8 companies
CBRECBRE Group5 questions · 2 reporting periods · 0 of 5 challenging
Calendar 2025 Q2
can you quantify what your exposure to the New York City market is, whether it's, I guess, revenue or some other metric
Show response
Bob estimated NYC represents approximately 5-6% of total company earnings, putting the market's significance in perspective relative to CBRE's global diversification.
what do you think it would take to kind of get back even close to that peak? And how long do you think that could take
Show response
Bob noted capital markets still 14% below pre-COVID peak; rate cuts, rental rate increases, and European stability would accelerate recovery but no single catalyst expected.
Calendar 2025 Q1
as long as the 10-year remains below 5%, it's kind of the key level that you can sort of maintain your pace in capital markets activity
Show response
Emma clarified both rate level and stability matter; 55-60% of originations are refinancings that need to continue regardless of rate environment.
activity slowed right after -- right at the beginning of this month but has actually accelerated since
Show response
Emma clarified March sales softness was brief with April seeing recovery, framing it as normal fluctuation rather than a trend.
how do you think longer term about how to discount that uncertainty in such a fluid situation as you think about the future of your business
Show response
Bob acknowledged limited unique visibility on tariff trajectory, noting their outlook embeds higher recession risk and more sideline behavior than previously assumed.
BXPBXP, Inc.3 questions · 3 reporting periods · 0 of 3 challenging
Calendar 2026 Q2
could you just help us think about any updated thoughts on where you expect that number to shake out for 2027?
Show response
Raised the leasing CapEx expectation and conceded a 2026 AFFO drag from free rent, with the benefit arriving in 2027. The operator introduced him by his middle name, Dylan.
Calendar 2025 Q2
Does the South of Mission seem to be kind of picking up and participating in that recovery
Show response
Doug confirmed South of Mission improving with AI demand. Rod noted Embarcadero Center demand remains financial/professional services while AI activity concentrates at 680 Folsom. Embarcadero completed 8 retail deals boosting vibrancy.
Calendar 2025 Q1
I just wanted to ask about 125 Broadway. I believe Biogen announced they're going to be moving to a new development elsewhere in Cambridge
Show response
Doug noted 125 Broadway is a true lab building likely to remain life science. Bryan said Biogen still assessing specialized needs within the building and BXP is highly confident in re-leasing given Kendall Square location.
AREAlexandria Real Estate Equities2 questions · 2 reporting periods · 0 of 2 challenging
Calendar 2025 Q2
Would you say those improvements on rents are kind of specific to those projects or that submarket
Show response
Peter said it is project-specific but confirms tenants are willing to pay for quality, citing both the build-to-suit lease and above-underwriting rents at One Alexandria Square.
Calendar 2025 Q1
your internal conversations, do you have a sense of where you think occupancy could bottom in the portfolio
Show response
Marc noted Q1 expirations were unusually concentrated, with most of the 768K sqft not expected to deliver until 2026. Joel mentioned alternative uses like AI driving faster-than-expected backfills.
INVHInvitation Homes2 questions · 2 reporting periods · 0 of 2 challenging
Calendar 2026 Q3
Just curious if you could give an update on what you're seeing in the private market for potential portfolio sales.
Show response
Said it is too soon to gauge portfolio pricing after rates rose, citing one $80 million joint venture purchase priced above a six cap.
Calendar 2026 Q2
The area has kind of been on fire from a multifamily standpoint, but it’s actually lagging Southern California
Show response
Tanner corrected the premise: the portfolio is Sacramento-weighted with no Bay Area presence, so Bay Area multifamily comparisons do not apply.
UDRUDR, Inc.2 questions · 2 reporting periods · 0 of 2 challenging
Calendar 2026 Q3
Just curious if you could comment on your latest thoughts on Seattle and just how demand feels on the ground.
Show response
Lacy cited AI jobs on the Eastside, aerospace hiring and low supply, with Seattle blends closer to 1% to 2% versus 12% to 13% in San Francisco.
Calendar 2026 Q2
talk about some of the markets where people leaving those markets has kind of slowed down the most
Show response
Lacy named Boston, Austin and San Francisco with specific year-over-year declines in the share of move-outs leaving the MSA.
CPTCamden Property Trust1 question · 1 reporting period · 0 of 1 challenging
Calendar 2026 Q2
if you could give us an update on migration in your markets so far this year
Show response
Jessett said domestic in-migration into Camden's markets continues and is normalizing rather than disappearing, citing researcher John Burns; 16% of second-quarter new renters came from outside the Sunbelt, up from 15.5% a year earlier and 14% before that.
Show 2 more companies
ESSEssex Property Trust1 question · 1 reporting period · 1 of 1 challenging
Calendar 2026 Q2
One of your peers called out tech layoffs as a pretty specific driver of softer pricing for the first half of the year.
Show response
Kleiman said tech layoffs are not a primary driver for Essex and pointed back to the broader economy.
MAAMid-America Apartment Communities1 question · 1 reporting period · 0 of 1 challenging
Calendar 2026 Q3
any considerations or anything nuanced to the supply picture that we are thinking about for 2027?
Show response
Said starts have run below the long-term average for three and a half years and 2027 deliveries will be below average under every forecast.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| CBRE CBRE Group | 5 | 0%none of 5 questions |
| BXP BXP, Inc. | 3 | 0%none of 3 questions |
| ARE Alexandria Real Estate Equities | 2 | —Rate withheld: fewer than 3 questions |
| INVH Invitation Homes | 2 | —Rate withheld: fewer than 3 questions |
| UDR UDR, Inc. | 2 | —Rate withheld: fewer than 3 questions |
| CPT Camden Property Trust | 1 | —Rate withheld: fewer than 3 questions |
| ESS Essex Property Trust | 1 | —Rate withheld: fewer than 3 questions |
| MAA Mid-America Apartment Communities | 1 | —Rate withheld: fewer than 3 questions |
- CBRECBRE Group · 5 questions0%none of 5 questions
- BXPBXP, Inc. · 3 questions0%none of 3 questions
- AREAlexandria Real Estate Equities · 2 questions—rate withheld: under 3 questions
- INVHInvitation Homes · 2 questions—rate withheld: under 3 questions
- UDRUDR, Inc. · 2 questions—rate withheld: under 3 questions
- CPTCamden Property Trust · 1 question—rate withheld: under 3 questions
- ESSEssex Property Trust · 1 question—rate withheld: under 3 questions
- MAAMid-America Apartment Communities · 1 question—rate withheld: under 3 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2025 Q1 | 5 | 0%none of 5 questions | 3 |
| 2025 Q2 | 4 | 0%none of 4 questions | 3 |
| 2025 Q3 | No questions recorded | — | — |
| 2025 Q4 | No questions recorded | — | — |
| 2026 Q1 | No questions recorded | — | — |
| 2026 Q2 | 5 | 20%1 of 5 questions | 5 |
| 2026 Q3 | 3 | 0%none of 3 questions | 3 |
- 2025 Q15 questions · challenge rate 0% (none of 5 questions) · 3 companies
- 2025 Q24 questions · challenge rate 0% (none of 4 questions) · 3 companies
- 2025 Q3No questions recorded
- 2025 Q4No questions recorded
- 2026 Q1No questions recorded
- 2026 Q25 questions · challenge rate 20% (1 of 5 questions) · 5 companies
- 2026 Q33 questions · challenge rate 0% (none of 3 questions) · 3 companies
Topics
Topics tagged on this analyst’s questions.
- Demand9
- Macroeconomic5
- Competitive Dynamics2
- Labor Market2
- Capital Allocation2
- M&A1
- Capex Investment1
- Margin1
- Pricing1
- Cloud & AI1
Show all 14 topics
- Geographic Expansion1
- Innovation & R&D1
- Credit1
- Trade Tariffs1